Nova Eye Medical Limited (ASX:EYE) Completes $6.6 Million Placement
Nova Eye Medical Limited (ASX:EYE) secures $6.6 million to expand operations and enhance growth in the ophthalmic technology sector.
Category: Healthcare
Nova Eye Medical Limited (ASX:EYE) Announces Capital Raise to Drive Growth
Nova Eye Medical (ASX:EYE) announces a capital raise to bolster its financial stability and operational growth amid increasing demand in the ophthalmology sector.
Hawthorn Resources Limited (ASX:HAW) Quarterly Activities Report
Hawthorn Resources Limited (ASX:HAW) highlights significant advancements in the Mt Bevan magnetite project and ongoing developments in the Anglo Saxon gold initiatives.
EVE Health Group (ASX:EVE) Announces Strategic Developments
EVE Health Group (ASX:EVE) shares updates on its operational achievements and financial performance, focusing on growth and strategic initiatives.
KNeoMedia Limited (ASX: KNM) Provides Quarterly Update
KNeoMedia Limited (ASX: KNM) outlines key financial developments and contract progress in its quarterly update.
Avecho Biotechnology Limited (ASX: AVE) Reports Q4 Activities
Avecho Biotechnology Limited reports progress in its Phase III CBD clinical trial and significant manufacturing achievements in Q4 2024.
Paradigm Biopharmaceuticals Ltd. (ASX: PAR) Announces Key Achievements in Quarterly Report
Paradigm Biopharmaceuticals announces key achievements in its December 2024 quarterly activities, including successful FDA protocol clearance and financial highlights.
Dome Gold Mines Limited (ASX:DME) Reports December Quarter 2024 Activities
Dome Gold Mines Limited (ASX:DME) highlights project progress and financial stability in its December quarter activities report.
Bluechiip Limited (ASX:BCT) Update on Strategic Review and Shareholder Support
Bluechiip Limited (ASX:BCT) updates on its strategic review and financial support from shareholders while aiming to lift share suspension.
Zelira Therapeutics (ASX:ZLD) Secures FDA Funding for Autism Program
Zelira Therapeutics secures US$681,000 funding for its HOPE® program and updates operational progress for Q2 FY2025.